Open AccessPain after uterine artery embolization with intrauterine device in situ
Author(s) -
Katherine Jane Chua,
Bruce McLucas
Publication year - 2020
Publication title -
bjr case reports
Language(s) - English
Resource type - Journals
ISSN - 2055-7159
DOI - 10.1259/bjrcr.20190128
Subject(s) - medicine , uterine artery embolization , abdominal pain , leukocytosis , embolization , lower abdominal pain , uterine artery , surgery , intrauterine device , pregnancy , family planning , population , gestation , research methodology , genetics , environmental health , biology
Uterine artery embolization (UAE) is a minimally invasive option for females with symptomatic leiomyomas. Studies detailing a possible risk with an intrauterine device (IUD) in situ during UAE are limited. A 43-year-old female (Gravida 2, Para 2) underwent UAE with an IUD in situ . On post-procedure day 2, the patient presented with severe lower abdominal pain and mild leukocytosis. Following removal of her IUD, the patient experienced immediate pain relief. Caution is given to clinicians who wish to perform UAE with an IUD in situ .